# BMED (iShares Health Innovation Active ETF)

iShares · Thematic ETFs · data as of Sep 11, 2026

BMED holds 50 stocks, and 39% of its weight is outside the S&P 500.

## Key facts

- BMED, already in the S&P 500: 60.8%, as of Sep 11, 2026.
- BMED, active share vs the S&P 500: 95.7%, as of Sep 11, 2026.
- BMED, top ten holdings: 42.6%, as of Sep 11, 2026.
- BMED, total return, 1 year: +23.6%, as of Sep 11, 2026.
- BMED, net assets: $13m (the issuer own daily fund list, as of Sep 11, 2026).
- BMED, expense ratio: 0.55% (485BPOS XBRL, Nov 21, 2025).

## BMED over each window to Sep 11, 2026

| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
| --- | --- | --- | --- | --- |
| 3 months | +15.8% | +3.3% | +12.5 pts | +16.6 pts |
| 6 months | +15.5% | +16.0% | −0.6 pts | −5.2 pts |
| 1 year | +23.6% | +17.5% | +6.1 pts | +0.6 pts |
| 3 years | +39.7% | +77.9% | −38.1 pts | −55.4 pts |
| Since launch | +29.6% | +145.3% | −115.7 pts | −132.5 pts |

## Every published field

| Field | Value | Source |
| --- | --- | --- |
| Theme | Healthcare innovation and GLP-1 | ETFIQ, editorial |
| Launched | Oct 1, 2020 | ETFIQ |
| Already in the S&P 500, by weight | 60.8% | ETFIQ |
| Active share vs the S&P 500 | 95.7% | ETFIQ |
| Already in the Nasdaq-100, by weight | 13.4% | ETFIQ |
| Active share vs the Nasdaq-100 | 97.8% | ETFIQ |
| Top ten holdings weight | 42.6% | ETFIQ |
| Holdings | 50 | ETFIQ |
| Holdings as of | Sep 10, 2026 | the issuer’s daily file |
| Top holdings | GILEAD SCIENCES 5.1%, MERCK & CO INC 5.0%, ABBVIE 4.7%, JOHNSON & JOHNSON 4.4%, THERMO FISHER SCIENTIFIC INC 4.2%, CHARLES RIVER LABORATORIES INTERNA 4.1%, EDWARDS LIFESCIENCES 3.9%, MODERNA 3.9%, IQVIA HOLDINGS 3.8%, BIOGEN 3.5% | ETFIQ |
| Net assets | $13m | the issuer own daily fund list, as of Sep 11, 2026 |
| Below its all-time high | −5.3% | ETFIQ |
| Expense ratio | 0.55% | 485BPOS XBRL, Nov 21, 2025 |
| Fee for the part that differs from the S&P 500, active expense ratio | 0.57% | ETFIQ |
| Closest funds by holdings overlap | BBH 35%, IBBQ 34%, PBPH 32%, GDOC 31%, PBE 27% | ETFIQ |

## Questions

### How much of BMED is in S&P 500 companies?

By its holdings published by its issuer for Sep 10, 2026, 61% of BMED by weight is stocks the S&P 500 already holds. Its active share against the index is 96%, so that share is the part doing something different.

### What does BMED hold?

50 positions as published by its issuer for Sep 10, 2026, with the top ten at 43% of the fund. The largest are GILEAD SCIENCES at 5.1%, MERCK & CO INC at 5.0%, ABBVIE at 4.7%.

### Has BMED beaten the S&P 500?

Over the year to Sep 11, 2026 BMED returned +23.6% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 6.1 points.

### What does BMED cost?

The prospectus expense ratio is 0.55% a year. Because 96% of the fund differs from the S&P 500, the fee on that differing part works out at 0.57%.


## Cite this page

ETFIQ, BMED, data as of Sep 11, 2026. https://etfiq.com/funds/bmed
Free to use with attribution; the underlying files are at https://etfiq.com/data/.

HTML: https://etfiq.com/funds/bmed  ·  JSON: https://etfiq.com/funds/bmed.json